| Date | Title | Description | Source |
| 08.04.2024 | TRACON Pharmaceuticals Announces Reverse Stock Split | SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stag... | einpresswi... |
| 29.03.2024 | Alphamab Oncology Reports Full Year 2023 Financial Results a... | SUZHOU, China, March 29, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported finan... | en.prnasia... |
| 05.03.2024 | TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2... | - | globenewsw... |
| 28.02.2024 | TRACON to Report Fourth Quarter and Year-End 2023 Financial ... | SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | einpresswi... |
| 20.11.2023 | TRACON Pharmaceuticals Announces License of Product Developm... | - | globenewsw... |
| 14.08.2023 | TRACON Pharmaceuticals Reports Second Quarter 2023 Financial... | SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | einpresswi... |
| 28.02.2023 | TRACON to Report Fourth Quarter and Year-End 2022 Financial ... | /EIN News/ -- SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCO... | einpresswi... |
| 27.12.2022 | TRACON Pharmaceuticals Announces up to $30M Non-Recourse Non... | - | globenewsw... |
| 27.12.2022 | TRACON Pharmaceuticals Announces up to $30M Non-Recourse Non... | Initial $3.5M Funding Maintains Cash Runway of Mid-2023
/EIN News/ -- SAN DIEGO, Dec. 27, 2022 (GLOB... | einpresswi... |
| 21.11.2022 | TRACON Pharmaceuticals Announces Dosing of First Patient in ... | /EIN News/ -- SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCO... | einpresswi... |
| 31.10.2022 | TRACON to Report Third Quarter 2022 Financial Results and Pr... | SAN DIEGO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 06.10.2022 | TRACON Pharmaceuticals Announces Results of Independent Data... | SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 14.09.2022 | TRACON Pharmaceuticals Announces Fast Track Designation by t... | SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinica... | globenewsw... |
| 06.09.2022 | TRACON Pharmaceuticals Announces $35 Million Non-Dilutive De... | SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinica... | globenewsw... |
| 29.08.2022 | TRACON Pharmaceuticals Announces Approval of IND for CTLA-4 ... | SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 10.08.2022 | TRACON Pharmaceuticals Reports Second Quarter 2022 Financial... | SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 08.08.2022 | TRACON Pharmaceuticals Announces Submission of IND Applicati... | SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 27.07.2022 | TRACON to Report Second Quarter 2022 Financial Results and P... | SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage... | globenewsw... |
| 26.07.2022 | TRACON Pharmaceuticals Announces Dosing of 36th Patient in E... | SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical... | globenewsw... |
| 02.06.2022 | TRACON Pharmaceuticals to Present at the Jefferies Healthcar... | SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage... | globenewsw... |
| 16.05.2022 | TRACON Pharmaceuticals to Present at the H.C. Wainwright Glo... | SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage ... | globenewsw... |
| 11.05.2022 | TRACON Pharmaceuticals Reports First Quarter 2022 Financial ... | SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq:TCON), a clinical s... | globenewsw... |
| 04.05.2022 | TRACON to Report First Quarter 2022 Financial Results and Co... | SAN DIEGO, May 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage ... | globenewsw... |
| 19.04.2022 | TRACON Pharmaceuticals Announces Amended ENVASARC Protocol A... | SAN DIEGO, April 19, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stag... | globenewsw... |
| 23.03.2022 | TRACON Pharmaceuticals to Present at the Maxim Group 2022 Vi... | SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stag... | globenewsw... |
| 15.03.2022 | TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2... | Announced FDA Approval of Amended ENVASARC Protocol, ENVASARC Interim Efficacy Data on Track for 2H2... | globenewsw... |
| 11.03.2022 | TRACON Pharmaceuticals to Present at the Oppenheimer 32nd An... | SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stag... | globenewsw... |
| 10.03.2022 | TRACON Pharmaceuticals Announces FDA Approval of Amended ENV... | SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stag... | globenewsw... |
| 04.03.2022 | TRACON to Report Fourth Quarter and Full Year 2021 Financial... | SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stag... | globenewsw... |
| 02.02.2022 | TRACON Pharmaceuticals Announces Initiation of Randomized Ph... | SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage... | globenewsw... |
| 27.12.2021 | TRACON Pharmaceuticals Announces Positive Results from the I... | Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial
Objectiv... | globenewsw... |
| 29.11.2021 | TRACON Pharmaceuticals Reports Regulatory Approval of Envafo... | First Approval of a Subcutaneously Administered Checkpoint Inhibitor
TRACON’s Pivotal U.S. Trial for... | globenewsw... |
| 11.11.2021 | TRACON Pharmaceuticals to Present at the Jefferies London Vi... | SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage... | globenewsw... |
| 03.11.2021 | TRACON Pharmaceuticals Reports Third Quarter 2021 Financial ... | SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | globenewsw... |
| 27.10.2021 | TRACON to Report Third Quarter 2021 Financial Results and Co... | SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | globenewsw... |
| 13.10.2021 | TRACON Pharmaceuticals Announces Appointment of Carol Lam to... | SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | marketscre... |
| 13.10.2021 | TRACON Pharmaceuticals Announces Appointment of Carol Lam to... | SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | globenewsw... |
| 11.08.2021 | TRACON Pharmaceuticals Reports Second Quarter 2021 Financial... | SAN DIEGO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | marketscre... |
| 22.07.2021 | TRACON Pharmaceuticals Announces $10 Million Bought Deal Off... | SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON) (“TRACON” or the ... | marketscre... |
| 20.07.2021 | TRACON Pharmaceuticals Announces Appointment of Brenda Marcz... | SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage... | marketscre... |
| 30.06.2021 | TRACON Pharmaceuticals Announces Appointment of Ya Huang as ... | SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage... | marketscre... |
| 29.06.2021 | TRACON Pharmaceuticals Announces Orphan Drug Designation for... | Application Included Clinical Trial Data from Soft Tissue Sarcoma Patients Treated with Envafolimab ... | marketscre... |
| 01.06.2021 | TRACON PHARMACEUTICALS, INC.
TRACON Pharmaceuticals Announc... | SAN DIEGO, June 01, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage... | marketscre... |
| 20.05.2021 | TRACON PHARMACEUTICALS, INC.
TRACON Pharmaceuticals Announc... | SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage ... | marketscre... |
| 03.05.2021 | TRACON PHARMACEUTICALS, INC.
TRACON Pharmaceuticals Announc... | SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage ... | marketscre... |
| 09.03.2021 | TRACON Pharmaceuticals to Present at the Oppenheimer 31st An... | SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stag... | globenewsw... |
| 08.03.2021 | TRACON Pharmaceuticals Announces Appointment of Lisa Johnson... | SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage... | globenewsw... |
| 02.03.2021 | TRACON Pharmaceuticals to Present at the H.C. Wainwright Glo... | SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stag... | globenewsw... |
| 18.02.2021 | TRACON to Report Fourth Quarter and Full Year 2020 Financial... | SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ... | globenewsw... |
| 30.09.2016 | TRACON Pharmaceuticals Announces a Strategic Licensing Colla... | - | jnjinnovat... |
| 28.09.2016 | J&J hands Tracon two drugs, outlines buyback; Zymewor... | Typically we see Big Pharmas in-licensing experimental drugs from small biotechs. But in a... | endpts.com... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 24.09.2014 | TRACON Pharmaceuticals Inks $27M Round |
SAN DIEGO, CA, Clinical stage biopharmaceutical company announced the successful completion of a $... | vcnewsdail... |
| 23.09.2014 | Tracon Pharmaceuticals Closes $27M Series B Funding | Tracon Pharmaceuticals, a San Diego, CA-based developer of treatments for cancer and age-related mac... | finsmes.co... |
| 22.04.2011 | TRACON Pharmaceuticals Raises $14M in Venture Capital Fundin... | TRACON Pharmaceuticals Inc., a San Diego, CA-based biopharmaceutical company developing treatments f... | finsmes.co... |
| 20.04.2011 |
TRACON Pharmaceuticals Raises $14M
| San Diego-based TRACON Pharmaceuticals, a firm developing cancer therapeutics, said this morning tha... | socaltech.... |
